Scopelianos Angelo
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Scopelianos Angelo. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| AXGN | Chief R&D Officer | Option Exercise | 2,500 | — | — | Mar 21, 2024 |
| AXGN | Chief R&D Officer | Award / Grant | 2,571 | — | — | Oct 13, 2023 |
| AXGN | Chief R&D Officer | Option Exercise | 2,500 | — | — | Mar 16, 2023 |
| AXGN | Chief R&D Officer | Tax Withholding | 286 | $9.44 | $2,700 | Dec 27, 2022 |
| AXGN | Chief R&D Officer | Award / Grant | 2,571 | — | — | Jul 19, 2022 |
| AXGN | Chief R&D Officer | Tax Withholding | 2,770 | $7.97 | $22,077 | Mar 16, 2022 |
| AXGN | Chief R&D Officer | Tax Withholding | 400 | $8.42 | $3,368 | Feb 15, 2022 |
| AXGN | Chief R&D Officer | Tax Withholding | 286 | $9.74 | $2,786 | Dec 27, 2021 |
| AXGN | Chief R&D Officer | Award / Grant | 2,572 | — | — | Jul 20, 2021 |
| AXGN | Chief R&D Officer | Award / Grant | 1,325 | — | — | Feb 17, 2021 |
| AXGN | VP Research & Development | Sale | 567 | $17.81 | $10,098 | Dec 27, 2020 |
| AXGN | VP Research & Development | Tax Withholding | 394 | $14.68 | $5,784 | Feb 18, 2020 |